Millennium Management’s Immix Biopharma IMMX Stock Holding History

Millennium Management’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.9M	Buy	1,750,200 +90,422	+5%	+$664K	0.01%	1729
2025 Q4	$8.68M	Buy	+1,659,778	New	+$6.83M	﹤0.01%	2413
2024 Q4	–	Sell	-21,521	Closed	-$32.1K	–	6185
2024 Q3	$32.1K	Sell	21,521 -4,779	-18%	-$9.62K	﹤0.01%	5745
2024 Q2	$52.1K	Sell	26,300 -27,981	-52%	-$64.3K	﹤0.01%	5411
2024 Q1	$167K	Buy	+54,281	New	+$210K	﹤0.01%	5439
2022 Q1	–	Sell	-20,470	Closed	-$73K	–	7157
2021 Q4	$73K	Buy	+20,470	New	+$70K	﹤0.01%	6373

Other funds holding IMMX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Millennium Management's IMMX Position: Q1 2026 in Review

Millennium Management increased its Immix Biopharma (IMMX) stake by 5.4% in Q1 2026, buying an estimated $664K and bringing the position to 1,750,200 shares worth $15.9M. The position accounts for 0.01% of the portfolio, ranked #1729.

Millennium Management first reported a position in IMMX in Q4 2021 and has held it in 6 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

Millennium Management held 1,750,200 shares of Immix Biopharma worth $15.9M as of Q1 2026.
Millennium Management bought 90,422 Immix Biopharma shares in Q1 2026, an estimated $664K.
Immix Biopharma made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1729 holding.
Millennium Management first reported a position in Immix Biopharma in Q4 2021 and has held it in 6 quarters since.
77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.